In vitro activity of fluoroquinolones against Mycobacterium abscessus and Mycobacterium chelonae causing infectious keratitis after LASIK in Brazil
Data
2005-08-01
Autores
Hofling-Lima, Ana Luisa 
Freitas, Denise de
Sampaio, Jorge Luiz Mello
Leao, Sylvia Cardoso
Contarini, Patricia
Tipo
Artigo
Título da Revista
ISSN da Revista
Título de Volume
Resumo
Purpose: To evaluate the in vitro activity of fluoroquinolones against Mycobacterium abscessus and Mycobacterium chelonae isolated from outbreaks of infectious keratitis in Brazil.Material and Methods: Micobacterial isolates were recovered from infectious keratitis cases related outbreaks that occurred in Brazil after LASIK for myopia. Two outbreaks occurred in Rio de Janeiro in 1998 and 1999, and 3 in Sao Paulo between 2000 and 2003. All laboratorial analysis, including molecular identification and antibiotic susceptibility testing with determination of the minimum inhibitory concentration (MIC) levels for ciprofloxacin, ofloxacin, gatifloxacin, and moxifloxacin, were performed at Universidade Federal de Sao Paulo in Brazil.Results: Fifteen samples were identified as M chelonae, and 3 were identified as M. abscessus. The outbreaks studied were designated SP-1 in 2000; SP-2 in 2000-2001; and SP-3 in 2003, R1 in 1988 and R2 in 1999. All but 1 of the M. chelonae were resistant to all fluoroquinolones with an MIC90 greater than 32 mu g/mL. The only susceptible isolate had MIC levels for ciprofloxacin, ofloxacin, gatifloxacin, and moxifloxacin of 0.38 mu g/mL, 0.032 mu g/mL, 0.047 mu g/mL, and 0.19 mu g/mL, respectively. MIC levels for all 3 M abscessus isolates tested were greater then 32 mu g/mL for all fluoroquinolones tested.Conclusions: Fluoroquinolone MICs for 17 M abscessus and M chelonae isolates recovered from infectious keratitis cases in Brazil indicate that they are not susceptible to these drugs in vitro. Further studies to investigate the in vivo effectiveness of fluoroquinolones against mycobacteria are required because in vitro tests do not support their use in the treatment of micobacterial keratitis in this particular geographic area.
Descrição
Citação
Cornea. Philadelphia: Lippincott Williams & Wilkins, v. 24, n. 6, p. 730-734, 2005.